UTC Chairman and CEO Louis Chênevert Named Chair of the Yale Cancer Center Advisory Board
Yale Cancer Center is pleased to announce the appointment of Louis Chênevert as Chairman of the Center’s Advisory Board. Mr. Chênevert is Chairman and Chief Executive Officer of United Technologies Corp. (NYSE:UTX).
“Yale Cancer Center is a critical asset in the fight against cancer, a disease that unfortunately still touches nearly every family,” said Mr. Chênevert. “I’m proud to work with the Advisory Board to ensure Yale Cancer Center and its talented staff have the resources needed to deliver life-saving care to families throughout our region.”
Mr. Chênevert has been a member of Yale Cancer Center’s Advisory Board since 2001. In addition, he served as co-chairman of the Campaign Committee for Smilow Cancer Hospital at Yale-New Haven from 2007 - 2010.
“Louis has been a tremendous supporter of Yale Cancer Center over the last decade and shares our continued commitment to ensuring that residents of Connecticut have access to the newest cancer therapies and best care possible. I am honored to have his leadership as Chair of our Advisory Board,” said Thomas J. Lynch, MD, Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital at Yale-New Haven.
The Yale Cancer Center Director’s Advisory Board is a group of active volunteers who are knowledgeable and informed advocates for the Center. This advocacy includes actively promoting the mission of Yale Cancer Center as well as participation in fundraising activities intended to provide financial support for Yale Cancer Center.
United Technologies Corp. is a diversified company providing high technology products and services to the global aerospace and building industries. UTC’s products include Carrier heating and air conditioning, Hamilton Sundstrand aerospace systems and industrial products, Otis elevators and escalators, Pratt & Whitney aircraft engines, Sikorsky helicopters, UTC Fire & Security systems and UTC Power fuel cells.
Yale Cancer Center is one of a select network of 40 comprehensive cancer centers
in the country designated by the National Cancer Institute and the only one in
Southern New England. Over 350 scientists and physicians at Yale Cancer Center collaborate to make the discoveries that advance the prevention and cure of cancer, while providing the very best in clinical cancer care to our patients at Smilow Cancer Hospital at Yale-New Haven in a supportive, patient-centered setting.